According to Rohto Pharmaceutical's latest financial reports the company's current earnings (TTM) are $0.28 B. In 2022 the company made an earning of $0.25 B a decrease over its 2021 earnings that were of $0.26 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $0.28 B | 14.23% |
2022 | $0.25 B | -3.95% |
2021 | $0.26 B | 42.03% |
2020 | $0.18 B | 7.4% |
2019 | $0.17 B | 5.46% |
2018 | $0.16 B | 3.59% |
2017 | $0.15 B | 16.9% |
2016 | $0.13 B | 0.77% |
2015 | $0.13 B | 37.32% |
2014 | $97.6 M | -38.99% |
2013 | $0.15 B | 1.03% |
2012 | $0.15 B | -12.98% |
2011 | $0.18 B | 10.2% |
2010 | $0.16 B | 43.58% |
2009 | $0.11 B |